Nuvectra™ Reports Third Quarter 2017 Financial Results
01 nov. 2017 16h01 HE
|
Nuvectra Corporation
PLANO, Texas, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today announced financial results for the third quarter ended September...
Nuvectra to Report Third Quarter 2017 Financial Results on November 1, 2017
24 oct. 2017 08h01 HE
|
Nuvectra Corporation
PLANO, Texas, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the...
First Spinal Cord Stimulator Implant Placed in Northern California by Dr. Goldthwaite Brings Pain Relief and Reduces Opioid Use for Local Injured Veteran
11 sept. 2017 08h00 HE
|
Nuvectra
PLANO, Texas, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Noel Goldthwaite, MD, senior surgeon and founding member at SpineCare Medical Group, Inc., is the first physician in northern California to implant...
Nuvectra to Participate in Morgan Stanley Global Healthcare Conference
30 août 2017 16h01 HE
|
Nuvectra
PLANO, Texas, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter...
Nuvectra™ Reports Second Quarter 2017 Financial Results
08 août 2017 16h01 HE
|
Nuvectra
PLANO, Texas, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today announced financial results for the second quarter ended June 30,...
Nuvectra to Present at the Wedbush PacGrow Healthcare Conference
28 juil. 2017 08h30 HE
|
Nuvectra
PLANO, Texas, July 28, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter...
Nuvectra to Report Second Quarter 2017 Financial Results on August 8, 2017
25 juil. 2017 16h01 HE
|
Nuvectra
PLANO, Texas, July 25, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the...
Nuvectra Files Regulatory Submission with FDA for Algovita® MRI-Conditional Approval
21 juin 2017 07h00 HE
|
Nuvectra
PLANO, Texas, June 21, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it has filed its regulatory submission with the...
Nuvectra™ Reports First Quarter 2017 Financial Results
09 mai 2017 16h01 HE
|
Nuvectra
PLANO, Texas, May 09, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31,...
Nuvectra to Present at the 18th Annual B. Riley Co. Investor Conference
03 mai 2017 08h01 HE
|
Nuvectra
PLANO, Texas, May 03, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter...